<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17434" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Amebic Colitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Taherian</surname>
            <given-names>Mehran</given-names>
          </name>
          <aff>University at Buffalo, Department of Pathology</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Samankan</surname>
            <given-names>Shabnam</given-names>
          </name>
          <aff>Mount Sinai</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Cagir</surname>
            <given-names>Burt</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mehran Taherian declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shabnam Samankan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Burt Cagir declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>10</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17434.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Amebic colitis results from invasive infection of the colonic mucosa by <italic toggle="yes">Entamoeba histolytica</italic>. Losch first reported disease due to&#x000a0;<italic toggle="yes">Entamoeba histolytica</italic> in 1875; he found amoebas in colonic ulcers at autopsy and showed that the disease could be experimentally induced in vivo by rectal inoculation with human feces. Other scientists have shown that amoeba is the cause of the disease.&#x000a0;<italic toggle="yes">Entamoeba histolytica</italic>&#x000a0;has a worldwide distribution but is uncommon in the United States, although it occurs with increased frequencies in patients with AIDS and men who have sex with other men. This&#x000a0;topic reviews the pathophysiology, histology, diagnostic evaluation, complications, and treatment of amebic colitis. Moreover, it highlights the role of the interprofessional team in educating the patients to prevent the disease and its complications.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the pathophysiology of amebic colitis.</p></list-item><list-item><p>Determine the best methods to diagnose amebic colitis.</p></list-item><list-item><p>Implement a 2-step medication treatment to eliminate amebic infection.</p></list-item><list-item><p>Communicate&#x000a0;the importance of collaboration and coordination among the interprofessional team to enhance patient care when encountering the extracolonic complications of amebic colitis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17434&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17434">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17434.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Amebic colitis results from an invasive infection of the colonic&#x000a0;mucosa by <italic toggle="yes">Entamoeba histolytica</italic> (<italic toggle="yes">E histolytica</italic>).<xref ref-type="bibr" rid="article-17434.r1">[1]</xref> Losch first reported disease due to <italic toggle="yes">E histolytica</italic> in 1875; he found amoebas in&#x000a0;colonic ulcers at&#x000a0;autopsy and showed that the disease could be experimentally induced&#x000a0;in vivo by rectal inoculation with human feces&#x000a0;(see <bold>Image.</bold>&#x000a0;Amebic Colitis). Other scientists have shown that amoeba is the cause of the disease. <italic toggle="yes">E histolytica</italic>&#x000a0;has a worldwide distribution but is uncommon in the United States. However, it occurs with increased frequencies in patients with AIDS and men who engage in sex with other men.&#x000a0;Symptoms vary widely and include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Dysentery with diarrhea and rectal bleeding mimicking irritable bowel disease (IBD)</p>
          </list-item>
          <list-item>
            <p>Liver abscesses</p>
          </list-item>
          <list-item>
            <p>Colonic granulomatous masses that can mimic carcinoma</p>
          </list-item>
          <list-item>
            <p>Complications include colonic perforation and fistulas or liver abscesses&#x000a0;<xref ref-type="bibr" rid="article-17434.r2">[2]</xref></p>
          </list-item>
        </list>
        <p><italic toggle="yes">E histolytica</italic>&#x000a0;can spread&#x000a0;by the ingestion of the amoeba cyst. The infective cysts can occur in contaminated food and water. Transmission by fecal-oral self-inoculation can also&#x000a0;happen in oral-anal sexual&#x000a0;contact.<xref ref-type="bibr" rid="article-17434.r3">[3]</xref></p>
      </sec>
      <sec id="article-17434.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p><italic toggle="yes">E histolytica</italic>, the protozoan parasite causing amebiasis, colonizes the intestinal&#x000a0;tract in 90% of susceptible individuals and presents asymptomatically. In 10%, the parasite overcomes the mucosal barrier of the colon and invades the lamina propria<xref ref-type="bibr" rid="article-17434.r4">[4]</xref>. Untreated invasive amebiasis can lead to severe colitis and fulminant infection, which is associated with high mortality.<xref ref-type="bibr" rid="article-17434.r5">[5]</xref> The host acquires parasite cysts through ingesting contaminated food&#x000a0;or water, mostly in areas or countries with poor sanitation.<xref ref-type="bibr" rid="article-17434.r6">[6]</xref></p>
      </sec>
      <sec id="article-17434.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p><italic toggle="yes">E histolytica</italic>&#x000a0;affects approximately 10% of the&#x000a0;global population, with over&#x000a0;100,000 deaths per year from amebic dysentery and liver abscesses.<xref ref-type="bibr" rid="article-17434.r5">[5]</xref> It is most prevalent in developing countries but is known to occur in Western countries, especially among recent immigrants, travelers returning from endemic areas, men who have sex with men, and immunocompromised individuals. Entamoeba histolytica parasite cysts' infection occurs through food or water intake and is&#x000a0;contaminated by human feces due to poor environmental sanitation or personal hygiene.<xref ref-type="bibr" rid="article-17434.r7">[7]</xref></p>
      </sec>
      <sec id="article-17434.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The gastric acid and the mucus barrier of the intestine serve as a protective mechanism that&#x000a0;prevents the <italic toggle="yes">E histolytica</italic> cysts from coming in contact with the intestinal epithelium. Encystation occurs in the terminal ileum or colon, which results in the trophozoites getting released into the lumen of the gut. Some individuals develop invasive amebic infection among those exposed, which is thought to be due to the interplay between the host's defensive factors and the virulence factor of the parasite. The&#x000a0;3 major virulence factors known to influence pathogenicity are:</p>
        <list list-type="order">
          <list-item>
            <p><bold>N-acetylgalactosamine-inhibitable lectin:</bold> Responsible for binding colonic mucin and host cell adhesion.</p>
          </list-item>
          <list-item>
            <p><bold>Amebapore:</bold>&#x000a0;A small peptide that facilitates the killing of host cells.</p>
          </list-item>
          <list-item>
            <p><bold>Cystine proteases:</bold>&#x000a0;Enzymes that facilitate the lysis of the host extracellular matrix.</p>
          </list-item>
        </list>
        <p>As the pathology progresses, the colonic mucosa becomes diffusely inflamed and edematous, with associated necrosis and sometimes intestinal wall perforation.<xref ref-type="bibr" rid="article-17434.r8">[8]</xref></p>
      </sec>
      <sec id="article-17434.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The classic endoscopic appearance is that of discrete areas of ulceration covered by exudate, with normal intervening mucosa; however, many cases depart from this description. Amebiasis may involve any part of the bowel but has a predilection for the cecum and ascending colon. The entire large bowel is involved in some cases, and there may even be an extension into the terminal ileum.<xref ref-type="bibr" rid="article-17434.r9">[9]</xref>&#x000a0;Perforation occurs in 5% to 10% of the cases. The microscopic appearance of a rectal biopsy is rather nonspecific. However, the relative paucity of inflammatory cells beneath the ulcer and the flask shape of the ulcer itself should alert the pathologist to consider this diagnosis. Confirmation rests on identifying trophozoites of <italic toggle="yes">E histolytica</italic>, which is visible in hematoxylin and eosin (H&#x00026;E) slides.</p>
        <p>Typically, the parasites measure 6 to 40 nm, are round or ovoid, and may demonstrate a surrounding halo;&#x000a0;they contain an abundant and vacuolated cytoplasm with small nuclei and a prominent nuclear&#x000a0;membrane. The organism's cytoplasm appears clean and free of ingested bacteria and vacuoles in a trichrome stain. Finely granular nuclear chromatin, demonstrating even distribution on the nuclear membrane, and the small central karyosome, stain a dark purple-red. Ingested RBCs are diagnostic for <italic toggle="yes">E histolytica</italic> trophozoites but usually are not present. The organisms are also detectable with periodic acid&#x02013;Schiff (PAS) and immunoperoxidase stains.<xref ref-type="bibr" rid="article-17434.r10">[10]</xref></p>
      </sec>
      <sec id="article-17434.s7" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p><italic toggle="yes">E histolytica</italic>&#x000a0;is cytotoxic to&#x000a0;some cell types, including neutrophils, T lymphocytes, and macrophages. The organism adheres to the intestinal mucosa, invades and disrupts the mucosal barrier, produces contact-dependent killing, and&#x000a0;stimulates apoptosis of the intestinal cells. The organism lyses and phagocytizes the cell. Cysteine proteases that destroy collagen and fibronectin mediate the invasion of the deeper layers of the intestinal wall. The host secretes proinflammatory cytokines, leading to an acute inflammatory response and migration of neutrophils and macrophages into the tissue. The organism can also secrete chemoattractants for neutrophils. It kills these cells by contact-dependent lysis, and the subsequent release of lysozymes, superoxides, and collagenases from the neutrophil granules produces additional damage to the intestinal mucosa.<xref ref-type="bibr" rid="article-17434.r6">[6]</xref><xref ref-type="bibr" rid="article-17434.r11">[11]</xref></p>
      </sec>
      <sec id="article-17434.s8" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Almost 90% of infections are asymptomatic. Individuals who are colonized but&#x000a0;remain asymptomatic&#x000a0;raise a significant risk to others because they are cyst passers and, therefore, infective. Symptomatic clinical infection may appear as an acute infection in the colon called amebic colitis. Amebic colitis typically presents with symptoms of diarrhea with blood in the stools, although the symptoms can be nonspecific. Amebic colitis has a more gradual onset than bacterial colitis. Amebic colitis can closely simulate ulcerative colitis or Crohn disease on clinical grounds.<xref ref-type="bibr" rid="article-17434.r12">[12]</xref></p>
        <p>The patient may have localized or diffused tenderness upon palpation during physical examination. Rarely, a palpable mass may be present. If undiagnosed and untreated, a patient may present with a toxic megacolon, which presents as an acute dilatation of the colon. This complication carries a high mortality due to associated necrosis and perforation. Fewer than 1% of patients with amebic colitis have associated extraintestinal infection, the commonest being a liver abscess.&#x000a0;Patients with liver abscesses may have symptoms such as fever, chills, and pain in the upper right quadrant or can be asymptomatic. Weight loss, increased white blood cell counts, or elevated liver enzyme levels may occur. Jaundice is usually absent.<xref ref-type="bibr" rid="article-17434.r13">[13]</xref> Lung abscesses may develop due to penetration of the diaphragm by amebae from hepatic abscesses or hematogenous spread. Invasion of the lung can cause&#x000a0;symptoms such as chest pain, dyspnea, and a productive cough.<xref ref-type="bibr" rid="article-17434.r14">[14]</xref></p>
      </sec>
      <sec id="article-17434.s9" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The gold standard for diagnosing amebic colitis is the detection of trophozoites of <italic toggle="yes">E. histolytica</italic> with ulcers in the microscopic examination of colonoscopic biopsies or, more infrequently, in fresh stool examination.&#x000a0;Patients with diarrhea are most likely to have trophozoites in the stool, which may be visible in direct wet mounts or trichrome-stained smears. Classically, the cecum and ascending colon are affected, and multiple punctate ulcers are observed with intervening normal tissue. The ulcers on histological examination typically appear as flask-shaped. In severe cases of amebic colitis, the ulcers may coalesce to look similar to ulcerative colitis.<xref ref-type="bibr" rid="article-17434.r7">[7]</xref></p>
        <p>Amebic liver abscesses often are detected by ultrasonographic or radiographic tests.<xref ref-type="bibr" rid="article-17434.r15">[15]</xref> Subsequent aspiration of the&#x000a0;abscess may&#x000a0;reveal&#x000a0;motile trophozoites and necrotic material composed of lysed cells. Serologic methods of detecting antibodies to <italic toggle="yes">E. histolytica</italic> are available; the results are positive in more than 90% of patients with the extraintestinal disease. These antibody levels rise after tissue invasion but are not protective. However, antibody tests are not particularly useful in distinguishing between past and current infections because antibodies can persist for years after an infection has resolved. Also, these tests provide limited information on patients from endemic areas. Tests that detect <italic toggle="yes">E&#x000a0;histolytica</italic> antigen in stool provide evidence of current infection. Point-of-care testing using immunochromatographic techniques is being developed to assist with the rapid diagnosis of <italic toggle="yes">E histolytica</italic> infection.<xref ref-type="bibr" rid="article-17434.r16">[16]</xref> Some are designed to detect the antigen in the stool, and others to detect antibodies in the serum. One disadvantage of these tests is that fresh, unpreserved stool is necessary for testing.</p>
      </sec>
      <sec id="article-17434.s10" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Amebic colitis requires treatment with combination therapy, and treatment options include luminal agents combined with tissue amebicides. The luminal amebicides include iodoquinol, diloxanide furoate, and paromomycin. The tissue amebicides include nitroimidazole (metronidazole), nitazoxanide, erythromycin, and chloroquine. Surgery is required when there is an associated liver abscess that needs drainage, or the patient presents as an emergency with a toxic megacolon with impending or free perforation.<xref ref-type="bibr" rid="article-17434.r17">[17]</xref></p>
      </sec>
      <sec id="article-17434.s11" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnoses include appendicitis, IBD, pseudomembranous colitis, and tuberculosis. Rarely,&#x000a0;<italic toggle="yes">E histolytica</italic> can affect the appendix, representing an extension of an infection of the right colon. Typical IBD&#x000a0;does not show&#x000a0;fibrinous materials containing organisms.&#x000a0;Ulcerative colitis characteristically shows more diffuse colonic involvement with mucosal distortion and lamina propria basal plasma&#x000a0;cell infiltration. Crohn's disease may show patchy mucosal ulceration but is distinguishable by fissure-like ulcers rather than flask-shaped ulceration; ulcers from Crohn's disease are mostly horizontal, whereas the amebic ulcers grow perpendicular to the long axis of the bowel.<xref ref-type="bibr" rid="article-17434.r18">[18]</xref><xref ref-type="bibr" rid="article-17434.r19">[19]</xref> In colon tuberculosis, grossly, ulceration with diffuse fibrosis extends through the wall, causing stenosis and obstruction. Coexistent tuberculous peritonitis presents in rare cases. Microscopically, typical granulomas are usually present.<xref ref-type="bibr" rid="article-17434.r20">[20]</xref></p>
      </sec>
      <sec id="article-17434.s12" sec-type="Treatment Planning ">
        <title>Treatment Planning </title>
        <p>Invasive colitis is treated with metronidazole (or alternative medications including tinidazole and nitazoxanide), followed by a luminal agent (such as paromomycin or diiodohydroxyquin) to kill intraluminal cysts. A 10-day course of metronidazole eliminates the intraluminal infection in most cases, but a second agent is still required. The recommended regimen of metronidazole for amebic colitis treatment is 500 to 750 mg&#x000a0;3 times per day in adults and 30 to 50 mg/kg per day for&#x000a0;5 to&#x000a0;10 days in children. The alternative regimen could be&#x000a0;2 g oral tinidazole, a single dose daily in adults for 3 days, and 50 mg/kg&#x000a0;per day oral in a single dose in children for 3 days.<xref ref-type="bibr" rid="article-17434.r21">[21]</xref></p>
        <p>With metronidazole alone, the parasites may persist in the intestine in as many as 40% to 60% of patients.<xref ref-type="bibr" rid="article-17434.r9">[9]</xref>&#x000a0;Thus,&#x000a0;the recommendation is&#x000a0;that patients with invasive amebiasis should receive a luminal&#x000a0;agent as the second line to eliminate surviving cysts in the bowel lumen. Luminal medications include paromomycin, diiodohydroxyquin, and diloxanide. Current guidelines recommend either iodoquinol 650 mg&#x000a0;orally&#x000a0;3 times a day in adults for 20 days, and 30 to 40 mg/kg&#x000a0;per day PO in&#x000a0;3 doses in children for 20 days, or paromomycin 25 to 35 mg/kg per day&#x000a0;by mouth in&#x000a0;3 doses for 7 days in&#x000a0;all ages.<xref ref-type="bibr" rid="article-17434.r22">[22]</xref></p>
      </sec>
      <sec id="article-17434.s13" sec-type="Toxicity and Adverse Effect Management">
        <title>Toxicity and Adverse Effect Management</title>
        <p>Broad-spectrum antibacterial therapy is necessary in patients who have known or suspected peritonitis. Surgical intervention is required in the setting of significant bowel perforation or abscesses that fail to respond to antibiotic therapy. Toxic megacolon often requires colectomy.</p>
      </sec>
      <sec id="article-17434.s14" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Drug treatment cures amebiasis in a few weeks. Intestinal amebiasis can be fatal in developing countries&#x000a0;among children, especially those younger than 5 of age. Worldwide, amebiasis is the third most common cause of death&#x000a0;due to parasitic infection after malaria&#x000a0;and&#x000a0;schistosomiasis, with at least&#x000a0;5 deaths per year in the United States.<xref ref-type="bibr" rid="article-17434.r23">[23]</xref></p>
      </sec>
      <sec id="article-17434.s15" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of amebic colitis include fulminant or necrotizing colitis, toxic megacolon,&#x000a0;bowel perforation, peritonitis, hemorrhage, stricture formation, or obstruction.<xref ref-type="bibr" rid="article-17434.r24">[24]</xref> Fulminant colitis occurs in 0.5% of cases, and patients present with&#x000a0;copious&#x000a0;dysentery, fever, leukocytosis, and&#x000a0;vague abdominal pain;&#x000a0;the bowel mucosa may undergo necrosis, leading to transmural perforation&#x000a0;and subsequent peritonitis.&#x000a0;Treatment with nitroimidazole and early surgical management is required; in the cases of intestinal perforation, broad-spectrum antibiotics are the therapy of choice. Toxic megacolon, seen in approximately 0.5% of cases and associated with high mortality, usually requires surgical intervention. It appears as total or segmental non-obstructive colonic dilatation plus systemic toxicity. The amebic liver abscess has been reported to vary between 3% and 9 % of amebiasis cases.<xref ref-type="bibr" rid="article-17434.r25">[25]</xref> Pleuropulmonary&#x000a0;amebiasis can also occur, which is&#x000a0;the second most&#x000a0;frequent extra-intestinal manifestation of amebiasis after amebic liver abscess.</p>
      </sec>
      <sec id="article-17434.s16" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>For travelers to endemic areas, preventing amebic infection involves avoiding untreated water and uncooked food, such as fruit and vegetables, that may have been washed in local water. Amebic cysts are resistant to chlorine at the levels used in water supplies, but disinfection with iodine may be effective.<xref ref-type="bibr" rid="article-17434.r26">[26]</xref>&#x000a0;Treatment for amebiasis should include informing patients of the medications' side effects and the need to adhere to the follow-up course of a luminal agent to eliminate the protozoa colonization and the symptoms and signs of its complications.</p>
      </sec>
      <sec id="article-17434.s17" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>All&#x000a0;<italic toggle="yes">E. histolytica</italic>&#x000a0;infections, even asymptomatic, should receive treatment, given the&#x000a0;high risk of&#x000a0;leading to invasive&#x000a0;infection and the risk of&#x000a0;passing the infection to the other&#x000a0;household members.</p>
      </sec>
      <sec id="article-17434.s18" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>It is crucial to understand amebiasis pathogenesis&#x000a0;to have&#x000a0;enhanced treatment and prevention. The clinical team, including nurses and pharmacists, should educate the patients on the significance of handwashing and hand hygiene after defecation and before feeding. Explanations to travelers about the risks&#x000a0;of eating&#x000a0;raw vegetables and fruits and drinking contaminated water are&#x000a0;recommended. Clinicians, including doctors, nurse practitioners, and physician assistants, should be aware of how to treat asymptomatic carriers to minimize the spread of infection and diminish the risk of developing invasive disease. The pharmacist should evaluate the medication choice, check for drug-drug interactions, and ensure patient compliance. The clinical team and nursing staff should work together to ensure that patients are well-educated regarding the risks of the disease and prevention techniques.</p>
        <p>In summary, amebic colitis requires an interprofessional team approach, including physicians, infectious disease specialists, specialty-trained infection control and gastrointestinal nurses, and pharmacists, collaborating across disciplines to achieve optimal patient results.&#x000a0;</p>
        <p>With drug treatment, a cure is possible in most patients. However, without drug therapy, failure to thrive and even death are common. The recovery with drug treatment may take a few weeks or months.</p>
      </sec>
      <sec id="article-17434.s19">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17434&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17434">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/amebic-colitis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17434">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17434/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17434">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-17434.s20">
        <fig id="article-17434.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Amebic Colitis <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.pathologyoutlines.com/">Pathology Outlines</ext-link>&#x000a0;</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="188929966_23302e86e6_z" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-17434.s21">
        <title>References</title>
        <ref id="article-17434.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Espinosa-Cantellano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez-Palomo</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis of intestinal amebiasis: from molecules to disease.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2000</year>
            <month>Apr</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>318</fpage>
            <page-range>318-31</page-range>
            <pub-id pub-id-type="pmid">10756002</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cooper</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Fleming</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Boman</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Zuckerman</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Varied Clinical Manifestations of Amebic Colitis.</article-title>
            <source>South Med J</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>108</volume>
            <issue>11</issue>
            <fpage>676</fpage>
            <page-range>676-81</page-range>
            <pub-id pub-id-type="pmid">26539949</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roure</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Valerio</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Soldevila</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Salvador</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-Rivas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sulleiro</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ma&#x000f1;osa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sopena</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mate</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Clotet</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Approach to amoebic colitis: Epidemiological, clinical and diagnostic considerations in a non-endemic context (Barcelona, 2007-2017).</article-title>
            <source>PLoS One</source>
            <year>2019</year>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>e0212791</fpage>
            <pub-id pub-id-type="pmid">30789955</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Begum</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Quach</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chadee</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Immune Evasion Mechanisms of Entamoeba histolytica: Progression to Disease.</article-title>
            <source>Front Microbiol</source>
            <year>2015</year>
            <volume>6</volume>
            <fpage>1394</fpage>
            <pub-id pub-id-type="pmid">26696997</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stanley</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Amoebiasis.</article-title>
            <source>Lancet</source>
            <year>2003</year>
            <month>Mar</month>
            <day>22</day>
            <volume>361</volume>
            <issue>9362</issue>
            <fpage>1025</fpage>
            <page-range>1025-34</page-range>
            <pub-id pub-id-type="pmid">12660071</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ralston</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Petri</surname>
                <given-names>WA</given-names>
              </name>
            </person-group>
            <article-title>Tissue destruction and invasion by Entamoeba histolytica.</article-title>
            <source>Trends Parasitol</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>27</volume>
            <issue>6</issue>
            <fpage>254</fpage>
            <page-range>254-63</page-range>
            <pub-id pub-id-type="pmid">21440507</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Domazetovska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Adhikari</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Watts</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gilroy</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Stark</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sivagnanam</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A 12-Year Retrospective Study of Invasive Amoebiasis in Western Sydney: Evidence of Local Acquisition.</article-title>
            <source>Trop Med Infect Dis</source>
            <year>2018</year>
            <month>Jun</month>
            <day>26</day>
            <volume>3</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">30274469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moonah</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Petri</surname>
                <given-names>WA</given-names>
              </name>
            </person-group>
            <article-title>Host immune response to intestinal amebiasis.</article-title>
            <source>PLoS Pathog</source>
            <year>2013</year>
            <volume>9</volume>
            <issue>8</issue>
            <fpage>e1003489</fpage>
            <pub-id pub-id-type="pmid">23990778</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haque</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Huston</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Houpt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Petri</surname>
                <given-names>WA</given-names>
              </name>
            </person-group>
            <article-title>Amebiasis.</article-title>
            <source>N Engl J Med</source>
            <year>2003</year>
            <month>Apr</month>
            <day>17</day>
            <volume>348</volume>
            <issue>16</issue>
            <fpage>1565</fpage>
            <page-range>1565-73</page-range>
            <pub-id pub-id-type="pmid">12700377</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kobayashi</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Koretoh</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Kamachi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ishigooka</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Matsushita</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sawaragi</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Cytologic demonstration of Entamoeba histolytica using immunoperoxidase techniques. Report of two cases.</article-title>
            <source>Acta Cytol</source>
            <year>1985</year>
            <season>May-Jun</season>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>414</fpage>
            <page-range>414-8</page-range>
            <pub-id pub-id-type="pmid">2860765</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ravdin</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Croft</surname>
                <given-names>BY</given-names>
              </name>
              <name>
                <surname>Guerrant</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Cytopathogenic mechanisms of Entamoeba histolytica.</article-title>
            <source>J Exp Med</source>
            <year>1980</year>
            <month>Aug</month>
            <day>01</day>
            <volume>152</volume>
            <issue>2</issue>
            <fpage>377</fpage>
            <page-range>377-90</page-range>
            <pub-id pub-id-type="pmid">6249882</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pittman</surname>
                <given-names>FE</given-names>
              </name>
              <name>
                <surname>el-Hashimi</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Pittman</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Studies of human amebiasis. I. Clinical and laboratory findings in eight cases of acute amebic colitis.</article-title>
            <source>Gastroenterology</source>
            <year>1973</year>
            <month>Oct</month>
            <volume>65</volume>
            <issue>4</issue>
            <fpage>581</fpage>
            <page-range>581-7</page-range>
            <pub-id pub-id-type="pmid">4355733</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>P&#x000e9;rez-Tamayo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Montfort</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Ramos</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ostria</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis of acute experimental liver amebiasis.</article-title>
            <source>Arch Med Res</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>203</fpage>
            <page-range>203-9</page-range>
            <pub-id pub-id-type="pmid">16380320</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nasrullah</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Haq</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ghazanfar</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sheikh</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Akhtar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zafar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nasir</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shaukat</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Abbas</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>A Unique Case of Empyema Secondary to Amoebic Liver Abscess.</article-title>
            <source>Cureus</source>
            <year>2017</year>
            <month>Jun</month>
            <day>21</day>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>e1377</fpage>
            <pub-id pub-id-type="pmid">28775917</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koizumi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Masuda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Uojima</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ichita</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tokoro</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sasaki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Egashira</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kimbara</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kako</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Endoscopic ultrasound-guided drainage of an amoebic liver abscess extending into the hepatic subcapsular space.</article-title>
            <source>Clin J Gastroenterol</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>232</fpage>
            <page-range>232-5</page-range>
            <pub-id pub-id-type="pmid">26204883</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tachibana</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kakino</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kazama</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Feng</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Asai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Umezawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nozaki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Makiuchi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kamada</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Horiki</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Masuda</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Development of a sensitive immunochromatographic kit using fluorescent silica nanoparticles for rapid serodiagnosis of amebiasis.</article-title>
            <source>Parasitology</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>145</volume>
            <issue>14</issue>
            <fpage>1890</fpage>
            <page-range>1890-1895</page-range>
            <pub-id pub-id-type="pmid">29739480</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r17">
          <label>17</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Jackson-Akers</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Prakash</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Oliver</surname>
                <given-names>TI</given-names>
              </name>
            </person-group>
            <chapter-title>Amebic Liver Abscess</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">28613582</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gajendran</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Loganathan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jimenez</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Catinella</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Umapathy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ziade</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hashash</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>A comprehensive review and update on ulcerative colitis.</article-title>
            <source>Dis Mon</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>65</volume>
            <issue>12</issue>
            <fpage>100851</fpage>
            <pub-id pub-id-type="pmid">30837080</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Langner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Aust</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ensari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Villanacci</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Becheanu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Miehlke</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Geboes</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>M&#x000fc;nch</surname>
                <given-names>A</given-names>
              </name>
              <collab>Working Group of Digestive Diseases of the European Society of Pathology (ESP) and the European Microscopic Colitis Group (EMCG)</collab>
            </person-group>
            <article-title>Histology of microscopic colitis-review with a practical approach for pathologists.</article-title>
            <source>Histopathology</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>66</volume>
            <issue>5</issue>
            <fpage>613</fpage>
            <page-range>613-26</page-range>
            <pub-id pub-id-type="pmid">25381724</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rathi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gambhire</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Abdominal Tuberculosis.</article-title>
            <source>J Assoc Physicians India</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>64</volume>
            <issue>2</issue>
            <fpage>38</fpage>
            <page-range>38-47</page-range>
            <pub-id pub-id-type="pmid">27730779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gonzales</surname>
                <given-names>MLM</given-names>
              </name>
              <name>
                <surname>Dans</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Sio-Aguilar</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Antiamoebic drugs for treating amoebic colitis.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2019</year>
            <month>Jan</month>
            <day>09</day>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>CD006085</fpage>
            <pub-id pub-id-type="pmid">30624763</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Escobedo</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Almirall</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Alfonso</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cimerman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rey</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Terry</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Treatment of intestinal protozoan infections in children.</article-title>
            <source>Arch Dis Child</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>94</volume>
            <issue>6</issue>
            <fpage>478</fpage>
            <page-range>478-82</page-range>
            <pub-id pub-id-type="pmid">19329448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gunther</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shafir</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bristow</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sorvillo</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Short report: Amebiasis-related mortality among United States residents, 1990-2007.</article-title>
            <source>Am J Trop Med Hyg</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>85</volume>
            <issue>6</issue>
            <fpage>1038</fpage>
            <page-range>1038-40</page-range>
            <pub-id pub-id-type="pmid">22144440</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fleming</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Ramirez-Vega</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Huerta-Alardin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zuckerman</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Clinical manifestations and endoscopic findings of amebic colitis in a United States-Mexico border city: a case series.</article-title>
            <source>BMC Res Notes</source>
            <year>2015</year>
            <month>Dec</month>
            <day>14</day>
            <volume>8</volume>
            <fpage>781</fpage>
            <pub-id pub-id-type="pmid">26666636</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Misra</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Misra</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Dwivedi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Barthwal</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Factors influencing colonic involvement in patients with amebic liver abscess.</article-title>
            <source>Gastrointest Endosc</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>59</volume>
            <issue>4</issue>
            <fpage>512</fpage>
            <page-range>512-6</page-range>
            <pub-id pub-id-type="pmid">15044887</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17434.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lotter</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tannich</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>The current status of an amebiasis vaccine.</article-title>
            <source>Arch Med Res</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>292</fpage>
            <page-range>292-6</page-range>
            <pub-id pub-id-type="pmid">16380335</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
